Thyroid awareness month

Thyroid awareness month

Jan 28, 2020

January month is the Thyroid awareness month, and it is a great way to comprehend the treatment, prevention, and causes of thyroid-related diseases and cancer for the people who are affected.
One of them is Thyroid eye disease, which is also known as Graves’ Orbitopathy or Ophthalmopathy that is an autoimmune disease. It occurs when the body’s immune system attacks the tissue surrounding the eye, causing inflammation in the tissues around and behind the eye.

Downloads

Article in PDF

Recent Articles
  1. Graves’ Ophthalmopathy Treatment Market: A Billion-Dollar Opportunity For Pharma Companies
  2. Late-Stage Thyroid Eye Disease Treatments: 4 Prominent Therapies to Consider
  3. Thyroid eye disease market: New therapies enter the TED market
  4. FDA Approves Xolair for Food Allergies; FDA Accelerated Approval for Iovance’s AMTAGVI; Astellas ...
  5. Ipsen to Acquire Albireo; Chiesi Farmaceutici to Buy Amryt Pharma; Takeda Presents Phase III Resu...
4-late-stage-thyroid-eye-disease-treatments
Articles

Late-Stage Thyroid Eye Disease Treatments: 4 Prominent Therapies to Consider

Pharma News for Novartis, Iovance, Certa, Innovent
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Approves Xolair for Food Allergies; FDA Accelerated Approval for Iovance’s AMTAGVI; Astellas and Kelonia Enter into Research and License Agreement; Fast Track Designation to Certa’s FT011; Innovent Announces Phase 3 Clinical Trial Updates for IBI311; Orphan Drug Designation to Cardiol’s Pericarditis Drug Candidate

Graves’ Ophthalmopathy Therapeutics Assessment
Articles

Graves’ Ophthalmopathy Treatment Market: A Billion-Dollar Opportunity For Pharma Companies

Graves’ ophthalmopathy
Graves’ Orbitopathy
Ophthalmopathy
Thyroid
Thyroid eye disease
Thyroid eye disease epidemiology
Thyroid eye disease market
Thyroid eye disease treatment
loader